Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukoplakia, Oral 1

Interventions

pembrolizumab 183 Cisplatin 159 Radiotherapy 77 Carboplatin 71 Radiotherapy, Intensity-Modulated 70 Cetuximab 68 Magnetic Resonance Spectroscopy 65 Nivolumab 64 Paclitaxel 52 Docetaxel 50 Specimen Handling 45 Radiation 34 Gemcitabine 33 Fluorouracil 31 Surveys and Questionnaires 28 Biopsy 27 toripalimab 26 Drug Therapy 26 Platinum 25 Surgical Procedures, Operative 24 Standard of Care 23 1,2-diaminocyclohexaneplatinum II citrate 23 cemiplimab 22 atezolizumab 20 Capecitabine 20 Ipilimumab 19 Chemoradiotherapy 19 tislelizumab 18 durvalumab 18 Taxes 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Photosensitizing Agents × Head & Neck × 1 year × Clear all

NCT07453472 2026-03-06

PDT CALCI HOL

All India Institute of Medical Sciences

Phase 3 Not yet recruiting

Leukoplakia, Oral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡